Back to results
US 2023/0144973 A1Published application
Use of amisulpride as an anti-emetic
AssigneeAcacia Pharma Limited
InventorsJulian Clive GILBERT, Robert William GRISTWOOD, Nicola COOPER, Gabriel FOX
Life of this patent
Estimating the term…
Abstract
Amisulpride is used in the therapy of nausea, vomiting or retches. The therapy may utilize a novel injectable formulation, in unit dosage form, comprising less than 50 mg amisulpride.
Claims2
A pharmaceutical composition comprising amisulpride in an amount of less than 50 mg per dose, and a pharmaceutically acceptable carrier.
A method for the prevention and/or treatment of post-operative nausea and vomiting, comprising administering amisulpride at a dose of less than 50 mg to a subject in need thereof.
Dependencies are inferred from the claim text.